Outcomes of a 2nd comparative analyze had been documented by Flinn et al. This is the phase III randomized Intergroup trial comparing FC routine as opposed to FAMP by itself in 278 patients getting their initially chemotherapy program for B-CLL. Dosages of FC schedule have been similar to the first https://menachemj665xjv9.theisblog.com/profile